Madrigal's Cholesterol Drug Succeeds in Mid-Stage Trial Post author:Sam Post published:February 7, 2018 Post category:BioPharma MGL-3196 was well-tolerated with primarily mild and some moderate AEs. Source: BioSpace You Might Also Like Why This Biotech Says It's Close to Curing the Type of Cancer That Killed March 16, 2017 GlaxoSmithKline Gets Expanded FDA Win for Fluarix January 11, 2018 <b>Jaguar Health</b> Announces Proposed Public Offering Of Common Stock September 17, 2017
